mms mohamad zahreddine

As Chief Information and Technology Officer and a member of the Executive Team at MMS, Mohamad Zahreddine is responsible for overseeing the operational and strategic aspects of the company’s Technologies, Quality and Compliance, Business Process Transformation, Product Development, Information Security, and overall Governance. 

He has established governance over key enterprise business processes and led the formation and implementation of a holistic technology, governance, and compliance strategy. By leading quality and compliance and developing tech-enabled enterprise strategies, Mohamad’s role is integral in developing solutions for both internal and customer processes. He has expertise in global ERP implementations, manufacturing systems and processes, engineering systems, sales and operations, and information security, including technical and quality certifications. He is proficient and experienced at identifying emerging technology needs within the pharmaceutical industry, including regulatory requirements and IT controls to support clinical trial execution and transparency.

In the pharmaceutical industry, technological advancements are constantly evolving to effectively bring life-changing therapies to market. Change should be embraced, not feared, in all levels of business in order to move forward.
Mohamad Zahreddine
Chief Operating Officer

Mohamad brings a visionary approach with nearly 30 years of global experience in Business and Information Technology (IT), Global Enterprise Resource Planning (ERP), and a strong passion for digital transformation. Prior to MMS, he held several global leadership positions in the industry and led multiple IT and business systems transformation initiatives. Mohamad holds a Master of Science in Computer and Information Systems from the University of Detroit Mercy and a Bachelor’s degree in Computer Information Systems from the Detroit College of Business. He is also a member of the Forbes Technology Council.

Suggested For You

perspectives

April 24th, 2025

How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy

perspectives

April 8th, 2025

Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements

news

April 3rd, 2025

Datacise by MMS Wins 2025 Data Breakthrough Award for Best Data Science Solution